Tamtam Try Tamtam free
The Chemours Company logo

The Chemours Company account plan

Chemical solutions for industries

At a glance

Chemours makes refrigerants, titanium dioxide pigment and fluoropolymers, with $5,808 million of FY2025 net sales and about 5,700 employees.

The Chemours Company is a global performance-chemicals maker spun off from DuPont on July 1, 2015, selling refrigerants (Opteon, Freon), Ti-Pure titanium dioxide pigment and fluoropolymers (Teflon, Viton, Krytox, Nafion). It serves refrigeration and air conditioning, coatings, plastics, semiconductor, electronics, transportation and industrial customers: about 2,400 customers in about 110 countries from 28 major production facilities in eight countries. FY2025 net sales were $5,808 million, with a net loss attributable to Chemours of $(386) million driven by the New Jersey PFAS settlement. It had about 5,700 employees at end-2025 and is led by President and CEO Denise Dignam.

Business units

Strategic priorities

Pathway to Thrive
The strategy launched in 2024 has four pillars: operational excellence, enabling growth, portfolio management and strengthening the long term; management says no portfolio action is off the table, including transformational partnerships.
AI infrastructure and liquid cooling
Growth investments concentrate on data center cooling, next generation refrigerant and semiconductor fabrication; data center and semiconductor products approach nearly half of Performance Solutions, and Chemours launched Phazon two-phase cooling fluids.
$1 billion EBITDA ambition
Management targets at least $1 billion of annual adjusted EBITDA from the core businesses with free cash flow conversion exceeding 40%, without a date.
Debt reduction
Debt reduction is the capital priority: EUR280 million of the euro term loan was repaid in 2026, and net leverage is targeted below 4.2x at end-2026 and sustainably below 3x longer term.
Resolve legacy PFAS liabilities
Chemours reached the North Carolina settlement, the final New Jersey Judicial Consent Order and EPA and West Virginia DEP settlements in 2026, while cutting targeted process emissions 80% since 2018 toward a 99% goal by 2030.

Latest results

In Q3 2026 (quarter to September 30), net sales rose 3% to $1,540 million on price, and net income attributable to Chemours was $196 million ($1.29 per diluted share) against $46 million, helped by $150 million received under the PFAS Insurance MOU. Adjusted EBITDA was $200 million, at the high end of guidance. TT Adjusted EBITDA rose to $85 million from $25 million and APM to $24 million, while TSS fell 30% to $136 million. Over nine months the company had a net loss of $(107) million after a $307 million tax provision. The 2026 outlook was cut to net sales growth of around 2% and Adjusted EBITDA of $775-800 million, and management expects earnings growth in 2027.

Investments and deals

Capex programme
Capex fell to $213 million in 2025 from $360 million; 2026 capex is guided at $220-230 million, and 2027 capex is not expected to rise by a large amount.
Kuan Yin site sale
Ten parcels of the former Kuan Yin, Taiwan site were sold for about $360 million, producing a $316 million nine-month gain in 2026, with proceeds used to reduce debt.
Phazon two-phase cooling launch
Phazon is the first brand Chemours has launched, aimed at AI data centers; product trials rose 70% year over year and qualification work includes Samsung and hyperscalers.
Refinancing
$700 million of 2034 Notes issued in March 2026 redeemed the $495 million notes due 2027 and $188 million of the 2028 notes.
2026 Restructuring Program
A company-wide restructuring under Pathway to Thrive produced $10 million of employee separation charges over the first nine months of 2026.

Challenges and risks

Legacy PFAS liabilities
Environmental remediation liabilities rose to $805 million at September 30, 2026 from $618 million, with accrued litigation of $553 million; about $1.1 billion remains under the $4 billion MOU cost-sharing cap.
Refrigerant aftermarket slump
After the 2025 AIM Act channel fill, management saw about a 25% drop in stationary AC aftermarket volume in 2026, with visibility returning toward the end of Q1 2027.
TiO2 overcapacity and imports
World TiO2 demand of about 7.3 million metric tons in 2025 compared with about 10 million metric tons of capacity; Chinese producers compete and Dignam says Chemours will defend the U.S. market.
Leverage and credit rating
Moody's cut Chemours to B1 from Ba3 in July 2026, and debt maturities include about $1,282 million in 2028.
Plant disruptions and input costs
Washington Works outages hit APM in 2025 and January 2026, and higher sulfur and raw material costs weighed on TSS and COGS.

What leadership says

“I want to be clear; no portfolio action is off the table where we see an opportunity to unlock a step change in value creation for our shareholders.”

Denise Dignam, President and CEO · Q2 2026 earnings call, August 5, 2026

“We expect Chemours to deliver earnings growth in 2027.”

Denise Dignam, President and CEO · Q3 2026 earnings call, November 3, 2026

“we will aggressively defend the U.S. market”

Denise Dignam, President and CEO · Q3 2026 earnings call, November 3, 2026, on TiO2 imports

“a very strategic new market for us with significant long-term growth”

Denise Dignam, President and CEO · Q3 2026 earnings call, November 3, 2026, on Phazon liquid cooling

Where a supplier can help

Data center go-to-market
Tied to the AI infrastructure priority and the Phazon launch: Chemours must get specified across the value chain with hyperscalers and OEMs, creating needs for market intelligence, partner programmes and technical sales support.
Lean operations and cost savings
Tied to Pathway to Thrive's operational excellence pillar and the 2026 Restructuring Program: process improvement, maintenance and reliability tools help avoid outages like those at Washington Works.
PFAS remediation and compliance
Tied to the legacy PFAS challenge: expanded drinking water programmes and consent decree work at Washington Works and Chambers Works need environmental engineering, monitoring and emissions-abatement services.
Working capital and treasury
Tied to the debt reduction priority and free cash flow target: cash management, receivables and procurement solutions that lift free cash flow conversion support deleveraging.
Pricing and channel analytics
Tied to TiO2 price increases and the refrigerant aftermarket slump: demand sensing and pricing tools help manage channel inventory and defend share against imports.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like The Chemours Company?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about The Chemours Company

What does Chemours do?

Chemours makes performance chemicals: Opteon and Freon refrigerants, Ti-Pure titanium dioxide pigment, and fluoropolymers such as Teflon, Viton, Krytox and Nafion for industrial, electronics and data center customers.

What is Chemours' revenue?

Net sales were $5,808 million in FY2025. In Q3 2026 net sales were $1,540 million, up 3%, and 2026 Adjusted EBITDA is guided at $775-800 million.

How many employees does Chemours have?

Chemours had about 5,700 employees at end-2025, 79% of them in the Americas.

Who leads Chemours?

Denise Dignam has been President and CEO since March 2024; Shane Hostetter has been CFO since July 2024.

What is Chemours' strategy?

Its Pathway to Thrive strategy combines cost reduction, growth in data center cooling, next generation refrigerant and semiconductor markets, portfolio reshaping and resolution of legacy PFAS litigation.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)